Explore how our CDMO services can take your biologic further at BIO 2024. Schedule a meeting.
Enhancing the path to clinic with an end-to-end solution that addresses supply chain, regulatory, and robust manufacturing processes for viral vectors.
Learn more about a true end-to-end offering for AAV and LV vector manufacturing